Data edition of
Residue An evidence-graded reference for peptide science

GHK-Cu clinical trials

Every study registered on ClinicalTrials.gov that lists GHK-Cu as an intervention, as of the data edition — what is being tested, in whom, by whom, and how far it has got.

Registered studies
3
Active or recruiting
2
Completed
1
With posted results
0
Planned or actual enrollment
187participants, summed
Registered studies of GHK-Cu by phase and status
PhaseStudiesBreakdown
Phase 2 1
0 completed, 1 active or recruiting, 0 stopped, 0 other
Phase 4 1
1 completed, 0 active or recruiting, 0 stopped, 0 other
Not applicable 1
0 completed, 1 active or recruiting, 0 stopped, 0 other
Figure 1. 3 studies on ClinicalTrials.gov match the registry search GHK-Cu OR "copper peptide" OR "copper tripeptide". Multi-phase studies are counted at their highest phase. Open the full trial feed

Conditions studied

  1. Acute Standardized Cutaneous Wounds (Punch-biopsy Wounds)1
  2. GHK and GHK-Cu Blood Levels1
  3. Cutis Laxa Facialis1
  4. Xeroderma1

Lead sponsors

  1. Hudson Biotech1
  2. LifeWave, Inc.1
  3. Austin Institute for Clinical Research1

The registry, study by study

Registration is not evidence of benefit; many registered studies never publish. Status and dates are as reported by sponsors to ClinicalTrials.gov.

Status
Phase

3 shown

Registered studies of GHK-Cu
StudyPhaseStatusStartnSponsor
NCT07706361Two-Part Study of the Effects of the X39 Patch on Circulating GHK and GHK-Cu Levels in Healthy Adults N/A Not yet recruiting Jan 2027 100 LifeWave, Inc.
NCT07437586Topical GHK-Cu Gel for Acute Skin Wound Healing Phase 2 Recruiting Feb 2026 60 Hudson Biotech
NCT05932732Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types. Phase 4 Completed Nov 2023 27 Austin Institute for Clinical Research

Run this search on ClinicalTrials.gov → Query term: GHK-Cu OR "copper peptide" OR "copper tripeptide"